Krystal Biotech, Inc. KRYS EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s EPS (basic)?
- Krystal Biotech, Inc. (KRYS) reported EPS (basic) of $1.91 in Q1 2026.
- How has Krystal Biotech, Inc.'s EPS (basic) changed year-over-year?
- Krystal Biotech, Inc.'s EPS (basic) increased by 54.0% year-over-year, from $1.24 to $1.91.
- What is the long-term trend for Krystal Biotech, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s EPS (basic) has grown at a 22.6% compound annual growth rate (CAGR), from -$3.13 to $7.08.
- What does EPS (basic) mean?
- The amount of profit attributed to each share of common stock, excluding the effect of potential share dilution.
- How do you interpret EPS (basic)?
- An increase indicates higher profitability per share, which is generally favorable for shareholders and stock valuation.
- How does EPS (basic) compare across companies?
- A standard valuation metric used by investors to compare profitability across companies of different sizes.